Skip to content
Disclosery

EXANE DERIVATIVES: QQQ position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on QQQ, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 9,371 QQQ shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 9,371 shares
    Change vs previous 13F +3,067 shares

    1.51% of the 13F portfolio, value $2,626,227.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 6,304 shares
    Change vs previous 13F +4,630 shares

    0.64% of the 13F portfolio, value $2,285,412.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 1,674 shares
    Change vs previous 13F +1,055 shares

    0.16% of the 13F portfolio, value $666,006.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 619 shares
    Change vs previous 13F -94 shares

    0.06% of the 13F portfolio, value $221,580.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 713 shares
    Change vs previous 13F -78 shares

    0.06% of the 13F portfolio, value $258,407.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 791 shares
    Change vs previous 13F -23 shares

    0.08% of the 13F portfolio, value $252,435.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 814 shares
    Change vs previous 13F -49 shares

    0.08% of the 13F portfolio, value $255,387.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 863 shares
    Change vs previous 13F not available

    0.08% of the 13F portfolio, value $239,775.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).